Download ![]() |
< Back |
28 Jun 2024 | |
Wockhardt Limited has informed the stock exchange regarding a press release dated June 28, 2024 titled "Successful use of investigational antibiotic Zaynich (Zidebactam/Cefepime -WCK 5222) to treat a cancer patient in US with chronic bilateral thigh infection caused by an extreme drug resistant Pseudomonas." | |
View all announcements for WOCKHARDT LTD. | Source: BSE India |